Company Product Description Indication Status
Synchron Inc., of Silicon Valley Stentrode Fully implantable device that can translate brain activity or stimulate the nervous system from the inside of a blood vessel, without the need for open brain surgery To enable patients with upper-limb paralysis regain functional independence The U.S. FDA granted breakthrough device designation

Notes

For more information about individual companies and/or products, see Cortellis.

No Comments